These previous findings prompted us to study B-cell subpopulations and their function in three unrelated TTD1 patients who presented with classical TTD1 features, developed susceptibility to infection in their early childhood and presented with hypogammaglobulinemia and/or decreased antibody response to vaccination. The gene discussed is ERCC2; the disease is agammaglobulinemia.